Venture Capital in Biotech

Joe McCracken, Genentech

Loading video...

Joe discusses the recent lack of investment in biotech. He explains that after the biotech bubble in 2000, VCs have been hesitant in investing in biotech companies, and this has led to a slowdown in innovation in the industry.  

Nov 30, 2006

More from this event

More on this topic